Published on in Vol 8, No 1 (2022): January
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/33311, first published
.
Journals
- Kang D, Kim S, Kim H, Lee M, Kong S, Chang Y, Sim S, Kim Y, Cho J. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study. JMIR Public Health and Surveillance 2023;9:e44105 View
- Sarker J, Carkovic E, Ptaszek K, Lee T. Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2024;44(5):383 View
- Golder S, O'Connor K, Wang Y, Klein A, Gonzalez Hernandez G. The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review. JMIR Public Health and Surveillance 2024;10:e59167 View
- Nezhurina E, Milchakov K, Abramova A. Social Media as a Source of Information for the Detection of Adverse Drug Reactions in Post-Marketing Surveillance: A Review. Safety and Risk of Pharmacotherapy 2024 View
- Zhang J, Wang X, Zhou Y. Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration. Frontiers in Pharmacology 2024;15 View